Price movement over the last 24 hours
MNC Kapital Indonesia Tbk vs Diagnos Laboratorium Utama Tbk. — how do they compare? MNC Kapital Indonesia Tbk trades at Rp50 (market cap 2.13T, 136K 24h volume), while Diagnos Laboratorium Utama Tbk. trades at Rp220 (market cap 310.75B, 159.2K 24h volume). The key difference: MNC Kapital Indonesia Tbk is far larger — about 6.9× Diagnos Laboratorium Utama Tbk.'s market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (159.2K versus 136K). Which is the better fit depends on your goals.
| BCAP | DGNS | |
|---|---|---|
Market Cap | 2.13T | 310.75B |
Volume | 136K | 159.2K |
Lot | 1.36K | 1.59K |
Turnover | 6.8M | 34.72M |
Average Price | 50 | 218.06 |
Value | 6.8M | 34.72M |
Indicative Equilibrium Price | 50 | 220 |
Indicative Equilibrium Volume | 1 | 6 |
Trailing returns across standard periods
Latest headlines on both assets
PT MNC Kapital Indonesia Tbk formerly PT Bhakti Capital Indonesia Tbk was established on 15 July 1999, resulting from the restructuring and consolidation of PT Bhakti Investama Tbk, its holding company. At the time it was established, the Company commenced its business activities in the securities sector, among others are financial advisory, brokerage, underwriting, and research and development. In 2003, the Company carried out a business consolidation and transformed into a holding company of several subsidiaries that are engaged in financial services sector, namely PT Bhakti Finance, PT Bhakti Securities, and PT Bhakti Asset Management.
Read more on BCAP →PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →